Clinical Trial Update: Study of STG-001 in Subjects With Stargardt Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial study of STG-001 in Stargardt Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• STG-001

Snippet

Sponsor: Stargazer Pharmaceuticals, Inc. | Conditions: Stargardt Disease-1 | Phase 2 | Status: COMPLETED